Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04144777 · ClinicalTrials.gov registry record · NA

Efficacy of Solarplast for Health and Oxidative Stress

A NA study of Healthy Aging and Oxidative Stress, sponsored by Deerland Enzymes.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT04144777 is a NA study of Healthy Aging and Oxidative Stress that has completed, run by Deerland Enzymes. The registered enrollment target is 84 participants, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04144777, a NA study of Healthy Aging and Oxidative Stress, has completed, sponsored by Deerland Enzymes.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Solarplast is a unique mixture of antioxidant enzymes and single antioxidant molecules that are capable of attack oxidants that cause damage to the cells in the human body and cause premature aging. This mechanism may provide protection from stress, such as free radicals, heat, infection, as well as reduce inflammation and participate in the repair mechanism of the intestinal tract. Participants will consume Solarplast, or placebo, for 45 days with blood draws at day-0 and -45 in order to assess antioxidant capacity.

Interventions

  • DIETARY_SUPPLEMENT Solarplast

Study Locations (1)

Georgia

  • Kennesaw State University - Kennesaw

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2019-07-15
Est. Completion 2020-05-01
Phase NA

Sponsor

Deerland Enzymes

3 total trials

What the Registry Record Tells You About NCT04144777

The ClinicalTrials.gov registry entry for NCT04144777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (29% lower). The listed sponsor is Deerland Enzymes, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy Aging appearing as the primary indexed condition, and to 1 intervention - of which Solarplast is the first listed.

NCT04144777 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04144777 about?

NCT04144777 is a clinical study titled "Efficacy of Solarplast for Health and Oxidative Stress". Solarplast is a unique mixture of antioxidant enzymes and single antioxidant molecules that are capable of attack oxidants that cause damage to the cells in the human body and cause premature aging. This mechanism may provide protection from stress, such as free radicals, heat, infection, as well as...

What is the current status of trial NCT04144777?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-07-15. Estimated completion is 2020-05-01.

What conditions does trial NCT04144777 study?

This clinical trial studies the following conditions: Healthy Aging, Oxidative Stress, Skin Health.

What interventions are being tested in trial NCT04144777?

The interventions under investigation include: Solarplast (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04144777?

This trial is sponsored by Deerland Enzymes, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04144777 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.